Allied Market Research

2026

Therapies For Resistant And Recurrent Metastatic Cancer Market

Therapies for Resistant and Recurrent Metastatic Cancer Market (2023-2032)

by Type (Breast Cancer, Endocrine Cancer, Leukemia, Lymphoma, Bladder, Colorectal, Kidney, Ovary, Pancreas, Prostate, Uterus, Thyroid, Others) and, by Treatment (Chemotherapy, Hormone Therapy, Biotherapy, Radiation Therapy, Surgery, Others)

LS : Medical Devices & Supplies

  • Feb 2026

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (30% Off) $3,690 $2,583
Business User License (30% Off) $5,820 $4,074
Enterprise License (30% Off) $9,870 $6,909
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Eswara Prasad
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst